Menstrual cycle normalization with dydrogesterone
- Authors: Podzolkova N.M.1, Tatarchuk T.F.2, Doshchanova A.M.3, Eshimbetova G.Z.4, Sumyatina L.V.1
-
Affiliations:
- Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
- Institute of Pediatrics, Obstetrics, and Gynecology, National Academy of Medical Sciences
- Medical University of Astana
- Tashkent Institute of Postgraduate Medical Education
- Issue: No 6 (2018)
- Pages: 70-75
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248194
- DOI: https://doi.org/10.18565/aig.2018.6.70-76
- ID: 248194
Cite item
Abstract
Full Text
About the authors
Nataliya M. Podzolkova
Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Email: podzolkova@gmail.com
Doctor of Medicine, Professor, Department of Obstetrics and Gynecology
Tatyana F. Tatarchuk
Institute of Pediatrics, Obstetrics, and Gynecology, National Academy of Medical Sciences
Email: ipag.gyn@femina-health.org
MD, professor, Corresponding Member of NAMS of Ukraine, Honored Worker of Science and Technology of Ukraine, Deputy Director for Research
Aygerim M. Doshchanova
Medical University of Astana
Email: talmas_medicus@mail.ru
MD, professor, chief freelance gynecologist-endocrinologist of the Ministry of Health of the Republic of Kazakhstan
Gulsara Z. Eshimbetova
Tashkent Institute of Postgraduate Medical Education
Email: kaf_ginekologiya-perinatal@tipme.uz
MD, Professor of the Department of Obstetrics, Gynecology and Perinatal Medicine
Liliana V. Sumyatina
Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Email: sumyatin@yandex.ru
Ph.D., Associate Professor of the Department of Obstetrics and Gynecology
References
- Marret H., Fauconnier A., Chabbert-Buffet N., Cravello L., Golfier F., Gondry J. et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 152(2): 133-7.
- Савельева Г.М., Сухих Г.Т., Серов В.Н., Манухин И.Б., Радзинский В.Е., ред. Гинекология. Национальное руководство. 2-е изд. М.: ГЭОТАР-Медиа; 2017. 1048с.
- Matteson K.A., Raker C.A., Clark M.A., Frick K.D. Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the Medical Expenditures Panel Survey. J. Womens Health (Larchmt). 2013; 22(11): 959-65.
- Trivedi N., Chauhan N., Vaidya V. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study. Gynecol. Endocrinol. 2016; 32(8): 667-71.
- Schindler A.E. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Maturitas. 2009; 65(Suppl. 1): S3-11.
- Podzolkova N., Tatarchuk T., Doshchanova A., Eshimbetova G., Pexman-Fieth C. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecol. Endocrinol. 2016; 32(3): 246-9.
- Соловьева А.В., Ермоленко К.С. Дифференцированный подход к выбору терапии у женщин с аномальными маточными кровотечениями. Акушерство и гинекология. 2018; 3: 157-160. https://dx.doi.org/10.18565/ aig.2018.3.157-160
- Дубровина С.О., Берлим Ю.Д. Гестагены в терапии эндометриоза. Акушерство и гинекология. 2018; 5: 150-5. https://dx.doi.org/10.18565/ aig.2018.5.150-155
- Schweppe K.W. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009; 65(Suppl. 1): S23-7
- Carp H.J.A. Progestogens and pregnancy loss. Climacteric. 2018; Mar 22: 1-5. doi: 10.1080/13697137.2018.1436166
- Tournaye H., Sukhikh G.T., Kahler E., Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum. Reprod. 2017; 32(10): 2152.
- Zhu X., Ye H., Fu Y. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation. Fertil. Steril. 2017; 108(3): 505-12. e2.
- Guideline of the European Society of Human Reproduction and Embryology (ESHRE). Recurrent pregnancy loss. 154p. Available at: https://www.eshre.eu/ Guidelines-and-Legal/Guidelines/Recurrent-pregnancy-loss.aspx
- Madden T., Secura G.M., Nease R.F., Politi M.C., Peipert J.F. The role of contraceptive attributes in women’s contraceptive decision making. Am. J. Obstet. Gynecol. 2015; 213(1): 46. e1-6.
- Guerra J.A., López-Muñoz F., Álamo C. Progestins in combined contraceptives. J. Exp. Clin. Med. 2013; 5(2): 51-5.
- Chen J.T., Kotani K. Different effects of oral contraceptive and dydrogesterone treatment on oxidative stress levels in premenopausal women. J. Clin. Med. Res. 2018; 10(2): 146-53.